Chc Healthcare Group · TWSE:4164
Chc Healthcare — Investor Presentation (July 2013)
22 slides from Chc Healthcare's investor presentation, July 2013
Slide 1: CHC Healthcare Group, July 2013
WY AE yp ViRRUARAA | CHC HEALTHCARE GROUP 4164 TT July, 2013
Slide 2: Disclaimer
Disclaimer • The information contained in this confidential document ("Presentation") has been prepared by CHC Health Care Group (the "Company"). It has not been fully verified and is subject to material updating, revision and further amendment. • While the information contained herein has been prep
Slide 3: Executive Summary
Executive Summary Full service solution provider for high-end Radiotherapy, Neurosurgery Full Service and Diagnostic Imaging Equipment Exclusive master distributor in Taiwan for premium brands Provider Dominant 55% share of the Taiwan installed base of radiotherapy Dominant equipment, via sale
Slide 4: Radiotherapy is our focus
Radiotherapy is our focus Radiotherapy sales, revenue 7% of sales are derived from sharing partnerships and value- ophthalmology & dentistry- added services in Taiwan related equipment and accounted for 93% of 2012 supplements. revenue. Radiotherapy Sales, 24% Dentistry, 1% The superior Ophthamology
Slide 5: Value-Added Services with a Robust Distribution Channel
Value-Added Services with a Robust Distribution Channel • CHC's equipment is used in 52 of the 68 local hospitals that have radiotherapy departments. • Our market share for Brachytherapy Direct equipment is 90%+. Selling • 12-15 year radiotherapy Value-added equipment Services Revenue revenue-sharin
Slide 6: CHC Provides a Full Spectrum of Services
CHC Provides a Full Spectrum of Services Manufacturer Clinic Planning Product Categories: Specialty Site Radiotherapy Construction Neurology CHC Health Care Group Operational Ophthalmology Consulting Dentistry Revenue Distribution Services Installation Sharing Diagnostic Partnerships Imaging Educati
Slide 7: We work with world-renowned brands…
We work with world-renowned brands… Radiotherapy and Neurology Ophthalmology and Dentistry 7
Slide 8: And Aggressively Introducing New Products
And Aggressively Introducing New Products Diagnostic X-Ray (DR X-Ray) Proton therapy 8
Slide 9: Value-added Services
Value-added Services CHC’s experienced consulting and service team is a critical factor in our success. Manufacturers rely on CHC to provide this operational support and after-sales service. CHC’s 30 years of investment in establishing, training and re-certifying its 60+ member team is a key differe
Slide 10: CHC's Competitive Advantage in China
CHC’s Competitive Advantage in China Complete Product Line Successful Taiwan Experience Beijing Full Service Solution Capability Clinical Education and Training Hunan Flexible Sales Model Fujian Guangxi Guangdong Cross-strait Medical Conferences Hainan
Slide 11: Radiotherapy Equipment Market in China
Radiotherapy Equipment Market in China • There are about 1,300 Class Ⅲ hospitals in Hospitals China. 7 of the Top 10 clinics use Elekta. ClassⅢ (~1,300) >500 beds Class Ⅱ • China is the third largest medical device hospitals market in the world and domestic (~6,000) > 100 beds manufacturers’ product
Slide 12: High Demand for Radiotherapy Services
High Demand for Radiotherapy Services Cancer Radiotherapy application rate in Taiwan and western countries 28.40% Cardio vascular diseases 80% Cerebral vascular diseases 70% 23.30% 60% Pneumonia Diabetes 50% 2.80% Injuries 40% 3.20% Chronic lower respiratory diseases 30% Unmet 3.20% 11.10% Hypertens
Slide 13: Diagnostic Imaging Products Account for Over 25% of the Global Medical Device Market
Diagnostic Imaging Products Account for Over 25% of the Global Medical Device Market Global Medical Device market breakdown Global Diagnostic Imaging Market breakdown Medical supply, 14.60% Bone densitometer, Others, 30.30% 2.00% Other, 0.70% CT, 9.80% X ray, 31.70% Diagnotic Imaging, 25.80% PET, 17
Slide 14: Proton Pencil Beam Scanning
Proton Pencil Beam Scanning Proton Therapy 14
Slide 15: Protons and Charged Particles
Protons and Charged Particles Protons give Conformal Dose and Low Integral Dose 15
Slide 16: Proton Design Flexibility
Proton Design Flexibility ProteusPLUS TM ProteusONE TM UNIVERSAL PROTON THERAPY SOLUTION COMPACT PROTON THERAPY SOLUTION Active and Passive treatment modes Active treatment only Profitable PT center for 1/6 the size 1800 m² 300 m² 16
Slide 17: Our Vision
Our Vision IBA Proton Therapy Product Philips Radiological Imaging Pipeline Equipment Swissray Radiological Imaging Equipment (Exclusive Greater China Distributor Product Line Expansion Ｗhite Essence Dental Clinic (Exclusive Greater China Distributor) Ophthalmology & Dentistry Yoshida Dental Equipme
Slide 18: We Aim to Become the Leading Medical Equipment Full Service Solutions Provider
We Aim to Become the Leading Medical Equipment Full Service Solutions Provider in the Asia-Pacific Region Belgium Sweden Germany Swiss USA Japan Swiss Germany Nederland USA Germany Israel USA Germany 18 18
Slide 19: Financial Highlights
Financial Highlights Revenue Gross Profit & Gross Margin 50% 2,500,000 1,400,000 46.3% 45% 41.7% 41.9% 1,995,368 1,989,670 1,200,000 40% 2,000,000 1,867,510 923,272 35% 1,000,000 833,824 30% 778,153 1,500,000 800,000 27.6% 25% 959,795 600,000 20% 1,000,000 15% 400,000 264,987 500,000 10% 200,000 5%
Slide 20: 2013 Q1 Highlights
2013 Q1 Highlights NT$ ,000 2013Q1 2012Q1 Change Revenue 368,644 343,201 7.4% Gross profit 67,312 98,005 -31.3% Operating profit 8,340 42,960 -80.6% Net profit 4,090 39,246 -89.6% Net profit attribute to 4,847 38,946 -87.6% shareholders EPS 0.04 0.36 -88.9% Key ratios % 2013Q1 2012Q1 Change Gross ma
Slide 21: Peer Comparison Charts
Peer Comparison Charts ROE Operating Margin 35% 80% 30% 60% 25% 23.0% 40% 37.1% 20% 32.5% 20.1% 28.3% 15% 20% 12.8% 12.8% 10% 5.8% 0% 5% 2009 2010 2011 2012 0% -20% -5% 2009 2010 2011 2012 -40% -10% -15% -60% CHC Pacific Hospital CCM Cowealth CHC Pacific Hospital CCM Cowealth Net Margin NT$ EPS 50%
Slide 22: Thank you
Human Care Makes the Future Possible Thank you 22
CHC Healthcare Group — Investor Presentation (July 2013) on 6ix